SCHEMBL12458604

SCHEMBL12458604

COC1[C@@H](OC)[C@H](O[C@H]2[C@H](OC)[C@@H](OS(=O)(=O)O)[C@@H](OC)O[C@@H]2COS(=O)(=O)O)O[C@@H](C(=O)O)[C@H]1O[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](OCCOCCOCCOCCCC(=O)[C@H](CCCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@@H]54)NC(=O)CCCCC(=O)C[C@H](NS(=O)(=O)c4c(C)cc(C)c(C)c4C)C(=O)C[C@H](Cc4ccc(C(C)=N)cc4)C(=O)N4CCCCC4)[C@H](OC)[C@H]3OC)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.42
▸ MDK P21741 4/20 0.39
▸ SETD7 Q8WTS6 1/20 0.36
▸ CASP3 P42574 2/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP2 P42575 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ CASP8 Q14790 1/20 0.33
▸ PDE6D O43924 1/20 0.32
▸ L3MBTL3 Q96JM7 1/20 0.32
▸ NSD2 O96028 1/20 0.32
▸ NSD3 Q9BZ95 1/20 0.32
▸ FOLH1 Q04609 5/20 0.31
▸ PSEN1 P49768 1/20 0.31
▸ PSEN2 P49810 1/20 0.31
▸ APH1B Q8WW43 1/20 0.31
▸ NCSTN Q92542 1/20 0.31
▸ APH1A Q96BI3 1/20 0.31
▸ PSENEN Q9NZ42 1/20 0.31
▸ GIGYF2 Q6Y7W6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12458591 1.00 F2 (0.42) F2MDKSETD7CASP3CASP1
SCHEMBL4732589 0.97 F2 (0.42) F2MDKSETD7CASP3CASP1
SCHEMBL12799315 0.97 F2 (0.45) F2MDKSETD7CASP3CASP1
SCHEMBL12799348 0.97 F2 (0.45) F2MDKSETD7CASP3CASP1
SCHEMBL12458605 0.97 F2 (0.45) F2MDKSETD7CASP3CASP1
SCHEMBL12799304 0.96 F2 (0.40) F2MDKSETD7CASP3CASP1
SCHEMBL12458597 0.94 F2 (0.43) F2MDKSETD7CASP3CASP1
SCHEMBL12458601 0.90 F2 (0.43) F2MDKSETD7PDE6DL3MBTL3
SCHEMBL12799295 0.88 F2 (0.47) F2
SCHEMBL12458583 0.88 F2 (0.47) F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120238512-A1 ANTITHROMBOTIC DUAL INHIBITORS COMPRISING A BIOTIN RESIDUE MSD OSS B.V. (NL) 2012-09-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238512-A1 ANTITHROMBOTIC DUAL INHIBITORS COMPRISING A BIOTIN RESIDUE BRS3, SERPINC1, TBXA2R F2 67/4885MDK 4805/4885SETD7 3957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback